Technical Analysis for REDX - Redx Pharma Plc

Grade Last Price % Change Price Change
D 64.0 0.00% 0.00
REDX closed unchanged on Thursday, April 22, 2021, on 0 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical REDX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -1.54%
Fell Below 50 DMA Bearish -1.54%
Expansion Pivot Sell Setup Bearish Swing Setup -1.54%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.54%
Older End-of-Day Signals for REDX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 9 days ago
Down 2% 9 days ago
Down 1% 9 days ago
20 DMA Support 9 days ago
Boomer Buy Entry 9 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Redx Pharma Plc Description

Redx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The Company is engaged in drug discovery across cancer, infection and autoimmune diseases. The Company has over two programs in its oncology research activity, Smoothened Hedgehog (SMO) and Bruton's Tyrosine Kinase (BTK), which has reached candidate nomination stage. The Company's oncology research activity also include Porcupine program, Colony Stimulating Factor-1 receptor (CSF-1) program, Indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibitor and Pan-Raf inhibitor. The Company's anti-infective candidate compound is an antibiotic that the Company has developed to treat a range of Gram-positive bacterial infections, including resistant strains, such as Methicillin-Resistant Staphylococcus Aureus (MRSA). Its product candidate, RDX003, is a class of antibiotic acting through the type II bacterial topoisomerases. It is also evaluating BTK inhibitor for immunological disorders.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Hedge Clinic Disease Cancer Branches Of Biology Diseases Medical Specialties Oncology Mr Dx Drug Discovery Disorders Autoimmune Diseases Infection Antibiotic Oxygen Bacteria Infectious Diseases Erase Infections Kinase Bacterial Diseases Healthcare Associated Infections Methicillin Staphylococcus Aureus Tyrosine Kinase

Is REDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 95.0
52 Week Low 9.275
Average Volume 22,343,776
200-Day Moving Average 58.04
50-Day Moving Average 65.13
20-Day Moving Average 66.93
10-Day Moving Average 66.45
Average True Range 5.05
ADX 39.81
+DI 9.61
-DI 8.63
Chandelier Exit (Long, 3 ATRs ) 64.84
Chandelier Exit (Short, 3 ATRs ) 75.16
Upper Bollinger Band 71.83
Lower Bollinger Band 62.02
Percent B (%b) 0.2
BandWidth 14.66
MACD Line 0.20
MACD Signal Line 0.75
MACD Histogram -0.5484
Fundamentals Value
Market Cap 125.02 Million
Num Shares 195 Million
EPS -5.20
Price-to-Earnings (P/E) Ratio -12.31
Price-to-Sales 19.92
Price-to-Book 55.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.50
Resistance 3 (R3) 71.00 68.00 70.25
Resistance 2 (R2) 68.00 66.09 68.25 69.83
Resistance 1 (R1) 66.00 64.91 67.00 66.50 69.42
Pivot Point 63.00 63.00 63.50 63.25 63.00
Support 1 (S1) 61.00 61.09 62.00 61.50 58.58
Support 2 (S2) 58.00 59.91 58.25 58.17
Support 3 (S3) 56.00 58.00 57.75
Support 4 (S4) 56.50